Lisa Ricciardi - Jun 10, 2022 Form 4/A - Amendment Insider Report for COGNITION THERAPEUTICS INC (CGTX)

Role
CEO & President, Director
Signature
/s/ James M. O'Brien, Attorney-in-Fact
Stock symbol
CGTX
Transactions as of
Jun 10, 2022
Transactions value $
$0
Form type
4/A - Amendment
Date filed
6/23/2022, 04:06 PM
Date Of Original Report
Jun 13, 2022
Previous filing
Oct 14, 2021
Next filing
Nov 16, 2022

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction CGTX Stock Option (Right to Buy) Award $0 +150K $0.00 150K Jun 10, 2022 Common Stock 150K $1.92 Direct F1, F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 This amendment is being filed solely for the purpose of correcting a scrivener's error in this item. The correct exercise price is "$1.92" as shown herein, and not "$1.98" as was inadvertently entered in the original filing.
F2 The option vests 25% on June 10, 2023, with the remaining 75% vesting in 36 equal monthly installments, subject to the Reporting Person's continued service through the applicable vesting dates.